July 13, 2017 / 5:47 AM / 2 months ago

Germany's Gerresheimer eyes pick-up in second half

FRANKFURT, July 13 (Reuters) - German drugs-packaging maker Gerresheimer said it expected business to pick up in the second half of this year after a second quarter that showed further evidence of caution by U.S. customers due to uncertainty over healthcare policy.

Sales fell 2.2 percent to 339.5 million euros ($388.49 million), in line with the average estimate of 340 million euros in a Reuters poll, while adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) fell 6 percent to 75.8 million euros, missing the average estimate of 77 million.

Gerresheimer forecast full-year revenues of 1.4 billion euros, an increase of around 2 percent, and adjusted EBITDA of around 320 million euros, an increase of roughly 4 percent.

“We expect that our business will visibly pick up again, especially in the fourth quarter,” CEO Uwe Roehrhoff said in a statement.

$1 = 0.8739 euros Reporting by Victoria Bryan and Georgina Prodhan

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below